Showing results 1 to 9 of 9
- 2024
- Jongwon Jeong. (2024). Development of bio-therapeutics for intractable disease: GFRAL antagonist antibody for alleviating chemotherapy-induced cachexia & Primed MSC-sEV for amelioration of COVID-19-induced ARDS. doi: 10.22677/THESIS.200000798073
- DGIST
- View : 60
- Download : 0
- 2024
- Hyejin Lee. (2024). Dual GPR40/GLP-1R agonist ameliorates hyperglycemia of type 2 diabetes. doi: 10.22677/THESIS.200000723580
- DGIST
- View : 115
- Download : 0
- 2024
- Yurong Gao. (2024). GLP-1R and GPR39 signaling modulate insulin secretion in pancreatic β-cells. doi: 10.22677/THESIS.200000723707
- DGIST
- View : 145
- Download : 0
- 2022
- Rubaiya Tabassum. (2022). Identification of target genes for ALS treatment using a vertebrate ALS model system. doi: 10.22677/thesis.200000592213
- DGIST
- View : 225
- Download : 0
- 2021
- Seong-Hyeon Byeon. (2021). Molecular Basis of Voltage-Gated Calcium Channel Regulation by Ancillary Proteins. doi: 10.22677/thesis.200000497185
- DGIST
- View : 158
- Download : 0
- 2023
- Sunkyung Park. (2023). Paraoxonase 2 is an endoplasmic reticulum (ER)-residing protein and protects dopaminergic neurons in the substantia nigra (SN) from neurotoxicity. doi: 10.22677/THESIS.200000687914
- DGIST
- View : 176
- Download : 0
- 2024
- Hanguk Ryu. (2024). Transcriptomic Analysis Reveals ATF4-Mediated Regulation of Incretin Response in Type 2 Diabetic Pancreatic Beta Cells. doi: 10.22677/THESIS.200000804773
- DGIST
- View : 32
- Download : 0
- 2024
- Hyuncheol Ro. (2024). XBP1s negatively regulates LXRα and cholesterol efflux through an E3 ligase RNF181. doi: 10.22677/THESIS.200000723954
- DGIST
- View : 107
- Download : 0
- 2014-08-18
- View : 564
- Download : 0
1